NextCure, Inc.

Healthcare · Biotechnology · United States

Last price 6.31 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 28.88M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company’s product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer’s disease; and NC605 an antibody that targets Siglec-15, as w...